Skip to main content
Fig. 5 | Antimicrobial Resistance & Infection Control

Fig. 5

From: Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia

Fig. 5

Network meta-analysis of clinical cure in pneumonia in mITT population. Comparisons should be read from left to right. The safety estimate is located at the intersection of the column-defining treatment and the row-defining treatment. Significant results are in bold and underlined. mITT, modified intention-to-treat population. VAN, vancomycin. LIN, linezolid. CEF2, ceftobiprole. SXT/RIT, trimethoprim/sulfamethoxazole plus rifampicin. TEL, telavancin. TEI, teicoplanin. VAN/RIF, vancomycin plus rifampicin. Q/D, quinupristin/dalfopristin OR, odds ratio. CI, confidence interval

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us